Skip to main content

病人用藥教育:加肥貓的煩惱~代謝症候群的預防與治療(中)

   資料來源:藥師週刊(第1764期)
   記者:三軍總醫院臨床藥學部 葉爵榮 藥師
   日期:
 
   

 

 

 

 

1994年,學者Pouliot提出內臟型肥胖(visceral obesity)是代謝性異常的主因,使用腰臀比值代表內藏型的脂肪堆積,之後演變為簡易腰圍測量來識別高危險群。 2001年,Despres等學者,建議測量腰圍以識別高危險群,統計顯示腰圍>90cm,TG>177mg/dl,有80%個案合併有致動 脈粥狀硬化之血脂異常與高胰島素血症,且增加20倍罹患心血管疾病之風險。亞洲男性較容易有中心型腹部肥胖(內臟型肥胖),過多的脂肪堆積在腹部及內臟, 相較於女性因皮下脂肪堆積形成下腹部肥胖,更容易發生中風、心血管疾病、冠狀動脈疾病和第二型糖尿病,相關併發症如表一。研究結論認為男性腰 圍>94cm,女性腰圍>80cm,必須採取生活及飲食習慣之改善行動,來預防慢性疾病產生。另根據2012年2月發表於Diabetes Obes Metab期刊的一篇回顧1980年至2010年1月間有關扭轉代謝症後群,預防第2型糖尿病及心血管疾病干預措施的系統整合分析文章指出,納入≧24 週,共13篇,3907人的相關研究隨機對照試驗,結果對心血管事件死亡率降低,或減少第2型糖尿病發病率,使用生活方式(飲食和/或運動)調整益處為對 照組3.81倍,(95%CI 2.47-5.88);藥物治療益處為對照組1.59倍(95%CI 1.04-2.45)。

 

參考資料

1. James BM. David MN. Joseph IW. Jean EM. The metabolic syndrome (insulin resistance syndrome or syndrome X). Uptodate. 2011.
2. Eckel RH. Alberti KG. Grundy SM. Zimmet PZ. The metabolic syndrome. Lancet. 2010; 375:181-183.
3. Wilson PW. Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinol Metab Clin North Am. 2004; 33: 467–481.
4. Laaksonen DE. Lakka TA. Lakka HM.?Nyyssonen K. Rissanent LK. Salonen JT. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med. 2002; 19 (6): 456-464.
5. C Enzinger. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Department of Neurology, Medical University Graz, Graz, Austria Neurology. 2005; 64:1704-11.
6. Pouliot MC. Despres JP. Lemieux S. Moorjani S. Bouchard C. Tremblay A. et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994; 73(7): 460-8.
7. Despres JP. Lemieux I. Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001; 322(7288):716-20.
8. Dunkley AJ. Charles K. Gray LJ. Camosso-Stefinovic J. Davies MJ. Khunti K. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes Obes Metab. 2012; 1-10.
9. http://www.obesity.org
10. Grundy S. Cleeman J. Daniels S. et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005; 112:2735.